Precision Medication

Open access

ISSN: 2950-5232

Precision Medication

Open access

Editor-in-Chief

Haibin Dai

Editorial Board

Precision Medication is an open-access, peer-reviewed journal that focuses on and rapidly reports high-level research findings related to precision medication. It aims to promote the application of re...

Precision Medication is an open-access, peer-reviewed journal that focuses on and rapidly reports high-level research findings related to precision medication. It aims to promote the application of research output in solving clinical problems and improving patient outcomes, and provides an open and shared platform for pharmacists, physicians, researchers and pharmaceutical R&D personnel. This will foster the construction of a precision medication disciplinary system and its integration with multiple disciplines.

The scope of the journal covers

  • Development of policies and guidelines related to precision medication

  • Novel research methodologies for precision medication

  • Construction and efficacy evaluation of precision medication system

  • Digital health and precision medication

  • Information technology strategy and precision medication

  • Pharmacoeconomics and precision medication

  • Methodological research associated with precision medication

  • Pharmacogenomics research and clinical medication

  • Pharmaco-metabonomics research and clinical medication

  • Pharmaco-intestinal lora research and clinical medication

  • Tumor targeted drugs

  • New drug development and transformation

  • Precision medication for chronic diseases

  • Precision medication of traditional Chinese medicine

Editorial Board

Society affiliation

Precision Medication is sponsored by the Chinese Hospital Association and supervised by the National Health Commission of the People’s Republic of China.   CHINESE HOSPITAL ASSOCIATION (CHA) | PROFILE The Chinese Hospital Association (CHA) is a national, professional, and non-profit social organization registered with the Ministry of Civil Aff...

Precision Medication is sponsored by the Chinese Hospital Association and supervised by the National Health Commission of the People’s Republic of China.

 

CHINESE HOSPITAL ASSOCIATION (CHA) | PROFILE

The Chinese Hospital Association (CHA) is a national, professional, and non-profit social organization registered with the Ministry of Civil Affairs and operates under the professional guidance of the National Health Commission of the People's Republic of China. Its membership primarily consists of secondary-level and above medical institutions, alongside community and township healthcare facilities, as well as research institutes, social organizations, and experts specializing in hospital operation and management. As of December 2024, the CHA comprises 60 branches and over 5,000 institutional members.

 

History and Governance

The CHA originated as the Chinese Hospital Management Society, founded in 1995, and was renamed the Chinese Hospital Association in 2005. Following the 4th National Member Representative Congress held on December 24, 2022, the 4th Board of Directors officially commenced its term.

Mission and Vision

Guided by Xi Jinping Thought on Socialism with Chinese Characteristics for a New Era, the CHA closely aligns its initiatives with the central governments strategic decisions and the core priorities of the National Health Commission. The association is dedicated to:

 

Uniting the forces of the national hospital industry to implement China's health policies for the new era;

Advancing healthcare system reform to foster high-quality development;

Formulating industry standards and specifications to strengthen self-regulation;

Aggregating expert wisdom to build an authoritative industry think tank;

Representing industry interests and safeguarding the legal rights of its members;

Expanding international exchanges and cooperation to contribute to the building of a global community of health for all.

Service Tenet

Through pragmatic and concrete actions, the CHA actively fulfills its mission of "Serving Members, Serving the Industry, Serving the Government, and Serving Society." By fully leveraging its role as a bridge and bond, the CHA strives to make significant contributions to protecting public health and advancing the "Healthy China" initiative.

https://www.cha.org.cn/?siteid=10000&type=1

 

News

Precision Medication is now indexed in DOAJ

Precision Medication is Now Welcoming Submissions!

Learn more

View all

Call for papers

Special Issue on Artificial Intelligence-Driven Precision Oncology

View all

Stay Informed

Register your interest and receive email alerts tailored to your needs. Sign up below.